NCT02322216

Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 383 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 10 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate olopatadine 0.2% QD (once per day) compared to olopatadine 0.1% BID (twice per day) in the treatment of ocular itching associated with allergic conjunctivitis.

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	Olopatadine Hydrochloride Ophthalmic Solution 0.2%
DRUG	Olopatadine Hydrochloride Ophthalmic Solution 0.1%
DRUG	Olopatadine 0.2% Vehicle	Inactive ingredients used as placebo comparator

Timeline

• Start date: 2014-12-01
• Primary completion: 2015-10-01
• Completion: 2015-10-01
• First posted: 2014-12-23
• Last updated: 2017-11-17
• Results posted: 2016-10-12